Background. Blocking the costimulatory pathway by CTLA-4 Ig, reactive with
both B7-1 and B7-2 costimulatory molecules, protects the kidney during acut
e ischemia/reperfusion injury. This study investigated whether and how B7-1
and/or B7-2 proteins are involved in renal ischemia/reperfusion injury (IR
I).
Methods. Uninephrectomized rats were submitted to warm renal ischemia (30 m
in) and received control monoclonal antibody (mAb: 17E3), anti-B7-1 (3H5).
anti-B7-2 (24F), a combination of anti-B7-1/B7-2, or CTLA-4 Ig. Renal funct
ion, morphology, and the kinetics of inflammatory cells were studied for a
ten-day period, Binding sites of the injected antibodies were detected by s
econdary staining with anti-mouse Ab.
Results. Compared with controls, acute renal failure (ARF) in the anti-B7-1
group was attenuated both functionally and morphologically. Anti-B7-1/B7-2
and CTLA-4 Ig also were protective in IRI. ARF was not altered by anti-B7-
2 treatment. Two hours after reperfusion, B7-1 was expressed along the endo
thelial cells of the ascending vasa recta. Expression of B7-1 increased ove
r time during the first 24 hours and decreased thereafter. Two hours after
reperfusion, adherence/accumulation of T cells and monocytes/macrophages wa
s found in the vasa recta of the ischemic kidney. Anti-B7-1-treated animals
had fewer T cells and monocytes/macrophages in the vasa recta compared wit
h controls. Leukocyte accumulation in these vessels after anti-B7-2 treatme
nt was not different from IRI controls,
Conclusion. These observations strongly support the key role of the B7-1 pr
otein in the protection of renal IRI through inhibition of T cell and monoc
yte adherence at the level of the ascending vasa recta.